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Background: The most advocated clinical method for diagnosing salivary dysfunction is to quantitate unstimulated
and stimulated whole saliva (sialometry). Since there is an expected and wide variation in salivary flow rates among
individuals, the assessment of dysfunction can be difficult. The aim of this systematic review is to evaluate the
quality of the evidence for the efficacy of diagnostic methods used to identify oral dryness.
Methods: A literature search, with specific indexing terms and a hand search, was conducted for publications that
described a method to diagnose oral dryness. The electronic databases of PubMed, Cochrane Library, and Web of
Science were used as data sources. Four reviewers selected publications on the basis of predetermined inclusion
and exclusion criteria. Data were extracted from the selected publications using a protocol. Original studies were
interpreted with the aid of Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool.
Results: The database searches resulted in 224 titles and abstracts. Of these abstracts, 80 publications were judged
to meet the inclusion criteria and read in full. A total of 18 original studies were judged relevant and interpreted for
this review. In all studies, the results of the test method were compared to those of a reference method.
Based on the interpretation (with the aid of the QUADAS tool) it can be reported that the patient selection criteria
were not clearly described and the test or reference methods were not described in sufficient detail for it to be
reproduced. None of the included studies reported information on uninterpretable/intermediate results nor data on
observer or instrument variation. Seven of the studies presented their results as a percentage of correct diagnoses.
Conclusions: The evidence for the efficacy of clinical methods to assess oral dryness is sparse and it can be stated
that improved standards for the reporting of diagnostic accuracy are needed in order to assure the methodological
quality of studies. There is need for effective diagnostic criteria and functional tests in order to detect those
individuals with oral dryness who may require oral treatment, such as alleviation of discomfort and/or prevention of
diseases.Background
Oral dryness is a complex condition, expressed as a
physiological deficiency with or without perceived dys-
function. Clinically, oral dryness may vary from a slight
reduction in salivary flow with transient inconvenience
to severe impairment of oral health and concomitant
psychological indisposition. Salivary dysfunction has
mainly been related to a decrease in salivary flow rate,
but the molecular composition of saliva has gained more
attention in understanding the complexity of the condition.* Correspondence: christina.diogo@ mah.se
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reproduction in any medium, provided the orSaliva has been shown to have multi- functional character-
istics as expressed by several families of salivary molecules,
each comprising multiple members that are multifunctional
and overlapping [1]. This explains the presence of a com-
pensatory mechanism in saliva and that the expression of
salivary dysfunction is most likely to be multi-facetted.
The prevalence of oral dryness reported in the litera-
ture varies from 10% to 80% [2-12].
Part of this variation might be explained by the fact that
there is no global consensus regarding the terminology
associated with oral dryness, although many authors distin-
guish between xerostomia, denoting the subjective feeling
and hyposalivation, denoting a decreased salivary flow rate
[13-17].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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factor of importance is pharmacotherapy. Decreased
salivary flow rate has been reported as a consequence
of treatment with various types of drugs but as for the
subjective feeling of oral dryness the total number of
drugs taken seems to be more important [18]. No age-
dependent decrease in salivary flow rate has been estab-
lished [19,20] although a higher prevalence of perceived
oral dryness has been reported with increased age [18].
This might be explained by an increased intake of
medication with increasing age.
Several systemic disorders such as Sjögren’s syn-
drome, diabetes mellitus, rheumatoid arthritis, and sys-
temic lupus erythematosus are also known to cause oral
dryness. In addition, radiotherapy to the head and neck
region is a factor of importance.
With regard to an increasingly elderly population and
its dependent use of medication, a multitude of negative
side effects associated with disturbed salivary function
will present a medico-socio-economic problem not only
for the individual per se but also for society in the near
future.
The most advocated clinical method for diagnosing
salivary gland dysfunction is to quantitate unstimulated
and stimulated whole saliva flow rates (sialometry). The
cut-off value for a very low unstimulated and stimulated
whole saliva flow rate is claimed to be ≤ 0.1 ml/min
and ≤ 0.7 ml/min, respectively which is generally referred
in the literature to studies by Ericsson and Hardwick
[21] and Sreebny and Valdini [4]. Attempts have also
been made to correlate perceived oral dryness to salivary
output with varying results. However, reports where the
patients describe their oral comfort/discomfort levels,
suggest weak to no correlation between measures of sal-
ivary flow rates and an individual’s own subjective de-
scription [4,22-24]. Symptoms of dry mouth often occur
when the salivary flow rate is reduced by about 50%, but
can also be experienced within what is regarded as the
normal salivary flow rate range [25]. Unless the mouth is
almost dry, without proper individual baseline informa-
tion it is almost impossible to ascertain if the level of a
patient’s salivary flow rate is actually below ‘normal’.
Since there is a great variability in individual salivary
flow rate and a wide range of flow rate is accepted,
the accurate assessment of dysfunction can be diffi-
cult. With this in mind, it can be argued if measure-
ments of salivary flow rates can be used as a discriminating
diagnostic tool.
Ghezzi et al. [26] studied the variation of stimulated
parotid and submandibular flow rates in a healthy popu-
lation of adults over a six-hour period. In accordance
with other investigators [25,27], they demonstrated that
salivary flow rates are not constant and that there exists
a broad range of stimulated parotid and submandibularflow rates among healthy individuals. These findings
were confirmed in the study by Burlage et al. [28]. They
determined the variation in stimulated parotid flow rate
for repeated collections. They also found a large degree
of similarity between the flow rates of the left and right
parotid glands in healthy subjects as well as in patients
with Sjögren’s syndrome.
Responses to standardized questions have been com-
pared to objective measures of major salivary gland out-
put in order to identify certain questions that with a
high degree of reliability predict true salivary gland dys-
function [22]. The results showed that questions focus-
ing on perceived oral dryness associated with eating
were highly indicative of salivary performance whilst the
most commonly heard complaints such as perceived oral
dryness at night and during the day had no significant
correlation with reduced salivary flow rate.
Furthermore, the individuals’ assessment of the quan-
tity of saliva as “too little” was highly predictive of
decreased salivary output.
The aim of this systematic review is to evaluate the
quality of the evidence for the efficacy of diagnostic
methods used to identify oral dryness.
Methods
The systematic approach of the literature review was
adapted according to Goodman [29] and consisted of the
following steps: specification of the problem, formulation
of a plan to conduct the literature search with specified
indexing terms, retrieval of publications and interpretation
of the evidence from the literature studied.
Specification of the problem
The following question was developed to articulate the
problem: What methods are used to diagnose oral dry-
ness and what is the efficacy of these methods?
Formulation of a plan, literature search, and retrieval
The first step of the search was to use Medical Subject
Headings (MeSH) and free text words to search the elec-
tronic databases PubMed (including MeSH Subheadings
and [All fields]), Cochrane Library, and Web of Science.”
The following search terms were identified on the
basis of Medical Subject Headings (MeSH) and within
the MeSH database these terms are defined as:
 Saliva: the clear, viscous fluid secreted by the
salivary glands and mucous glands of the mouth and
containing mucins, water, organic salts, and ptylin.
 Xerostomia: decreased salivary flow.
 Diagnostic techniques and procedures: methods,
procedures, and tests performed to diagnose
disease, disordered function, or disability. Year
introduced: 1998.
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with no nicotinic effects. Pilocarpine is used as a
miotic and in the treatment of glaucoma.
The above mentioned MeSH terms were combined by
using the Boolean operator ‘OR’ with free text words
within a search facet.
Since this review focused on diagnostic methods and
an initial search resulted in a number of publications on
intervention with pilocarpine, the decision was made to
confine the search by excluding those studies.
Exclusion of studies on intervention with pilocarpine
was obtained by using the Boolean operator ‘NOT’ in
the search.
To be included in this review, publications that
described a method for diagnosing oral dryness were
searched. The inclusion and exclusion criteria are pre-
sented in Table 1.
The search was limited to publications with an Entrez
date in the period from January 1, 1966 to February
22, 2011.
The decision to include the article was made by read-
ing the title and the abstract. Four authors (CDL, CW,
MS and CC) screened all titles and abstracts independ-
ently for possible inclusion. When an abstract was con-
sidered by at least one author to be relevant, the full text
was obtained for independent assessment against the
stated inclusion criteria (Table 1) with the aid of a proto-
col (Additional file 1: Table S1). Any disagreement was
resolved by discussion among the reviewers.
The protocol used in the assessment against the stated
inclusion criteria.
Will the study be included in the systematic review?
Yes No.
The second step was to search by hand the reference
lists of the original studies that had been found relevant
in the first step. Reference lists of reviews were also
searched. Titles containing words suggesting diagnostic
measures and techniques of oral dryness were sought.
Inclusion and exclusion criteria were also considered
in the hand search. The abstracts of the selectedTable 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Human studies Review articles and abstracts
Oral dryness primary condition Studies on pharmacologic intervention









Studies where oral dryness is a
secondary outcome variable
Articles written in English
Inclusion and exclusion criteria for the retrieved studies.references were obtained and when considered relevant
by at least one author, the publication was ordered in
full text. Book chapters and reviews were excluded, since
the search focused on original studies.Data extraction
Data were extracted on the following items: year of pub-
lication; study objectives; study design; study population;
control group; test method; reference method; and
authors’ conclusion.
Original studies that presented a method for diagnosing
oral dryness were interpreted according to the Quality
Assessment of Diagnostic Accuracy Studies (QUADAS)
tool [30].
In the present review, a modified protocol comprising
15 questions was applied, as presented in Table 2.
The same reviewers assessed the articles separately.
Any interexaminer disagreements were resolved by dis-
cussion on each article to reach a consensus.Results
The number of publications retrieved, read and inter-
preted is presented in Figure 1.
The database searches resulted in 224 titles and
abstracts. Of these abstracts, 80 publications were
judged to meet the inclusion criteria and read in full.
Data were extracted according to the pre-established
protocol. Animal studies and publications in a language
other than English were excluded. Publications using a
sialogogue (not only pilocarpine) as intervention were
excluded. Furthermore, studies where oral dryness was
not described as a primary condition, studies where the
conditions for the donors were not standardised and stud-
ies that did not include a control group were excluded.
Studies were oral dryness was a secondary outcome vari-
able, i.e. studies reporting oral dryness as a secondary find-
ing to e.g. treatment or medication, but not to general
diseases e.g. Sjögren’s syndrome, were also excluded.
This resulted in 11 original studies being considered
relevant for the review. The hand search of the reference
lists of 11 original studies and 20 reviews resulted in an
additional 60 abstracts. After these abstracts had been
read, 24 publications were selected and read in full and
data were extracted. After the publications had been
read in detail, seven were selected.
A total of 18 original studies were interpreted for this
review [4,31-47].
Preliminary evaluation of the included studies revealed
heterogeneity with respect to inclusion criteria, test
method and reference method. Consequently, it was not
possible to conduct a quantitative data synthesis leading
to a meta-analysis.
Table 2 Protocol based on the Quadas tool for interpretation of relevant original studies
Yes No Unclear
1 Was the spectrum of patients representative of the patients who will receive the test in practice? () () ()
2 Were the selection criteria clearly described? () () ()
3 Is there a diagnostic reference standard? () () ()
4 If so, is the reference standard likely to correctly classify the target condition? () () ()
5 Is the time period between reference standard and index test short
enough to be reasonably sure that the target condition did not
change between the two tests?
() () ()
6 Did the whole sample or a random selection of sample, receive verification using a reference
standard of diagnosis?
() () ()
7 Was the execution of the index test described in sufficient detail to permit replication of the test? () () ()
8 Was the execution of the reference standard described in sufficient detail to permit replication of the test? () () ()
9 Were the index test results interpreted without knowledge of the results of the reference standard? () () ()
10 Were the reference standard results interpreted without knowledge of the results of the index test? () () ()
11 Were the same clinical data available when test results were interpreted as would be available
when the test is used in practice?
() () ()
12 Were uninterpretable/intermediate results reported? () () ()
13 Were withdrawals from the study explained? () () ()
14 Are data presented on observer or instrument variation that could affect the estimates of test performance? () () ()
15 Were appropriate results presented (percentage of correct diagnoses, sensitivity, specificity, predictive values,
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Seven of the included studies [31,33,34,36,37,43,44]
aimed at examining the potential use of different tests or
a combination of tests for the diagnosis of Sjögren’s syn-
drome. The remaining 11 studies [4,32,35,38-42,45-47]
described different methods for determining salivary
hypofunction.
Sixteen of the studies [31-34,36-47] were case control
studies, and two [4,35] were cross sectional studies.
Five studies were performed in the USA [4,31,39,42,46],
two in The Netherlands [36,37], two in Sweden [32,34],
one in Egypt [33], one in Great Britain [35], one in Japan
[38], one in South Korea [40], one in Spain [41], one in
Denmark [43], one in France [44], one in Mexico [45]
and one in Israel [47].
Study populations and control groups
The majority of de individuals included in the study
groups were individuals with Sjögren’s syndrome (Table 3).
In six studies [4,38,40,42,46,47] the study population con-
sisted of individuals with symptoms of and/or findings of
oral dryness. In one study [35], subjects were participants
in a cross sectional general health survey, randomly
selected from a population register.
The control groups consisted mainly of age- and
gender-matched healthy individuals. In two studies, the
control group consisted of individuals with normal saliv-
ary secretion rates [32,42]. One study [34] includedindividuals with symptoms of dry mouth in the control
group, and in one study [37] the control group consisted
of individuals with Sjögren’s syndrome.
The number of included individuals in the study
populations varied between 16 and 341 and in the
control groups between 12 and 372.
Two studies did not report age and gender [31,47] for
individuals included in the study populations or control
groups. Two studies [33,44] did not state gender for
individuals included in the control groups. Two studies
[38,42] reported age and gender for all included subjects.
The female/male ratio in the study populations 783/
273 [4,32-37,39-41,43-45,47] and control groups were
and 586/309 [4,32,34,36,37,39-41,43,45,46], respectively.
Index test methods and reference methods
A variety of index test methods were used in the
included articles (Table 4).
In general terms, the index tests could be divided into
five categories:
(1) Secretion tests; including sialometry and
sialochemistry,Oral Schirmer’s test, secretion
composition using protein separation techniques,
total protein content, electrolyte content and
specific protein content with immunological
tests or iodine starch reactions (amylase)
[31,32,36-38,41]
Figure 1 Flow chart. Flow chart and selection process of the included publications.
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residual wetness tests, salivary smears and biopsies
[33,46]
(3) ‘Functional’ tests; including dissolutions tests of
candy or wafers [45,47]
(4) Glandular morphology; including scintigraphy or
sialography [31,36]
(5) Questionnaires and/or interviews [4,34].
Some studies used a combination of tests to assess sal-
ivary gland hypofunction [40,42-44]. All studies used sia-
lometry as a reference standard when evaluating the
different index tests. However, different secretions, in-
cluding stimulated and unstimulated glandular saliva, as
well as unstimulated whole saliva were used (Table 5).
Eleven of the included studies [31-37,41,43-45] used
established criteria for the classification of Sjögren’s syn-
drome as reference methods. Seven of these studies
[31,35-37,41,43,44] used the European Community Study
Group on diagnostic criteria for Sjögren’s syndrome as
reference method [48-52]. Two studies [32,34] used the
Copenhagen Criteria for the classification of Sjögren’ssyndrome [53] as reference method and two studies
[33,45] used the proposed criteria for Sjögren’s syndrome
according to Fox et al. [54] as a reference method. The
cut-off values defining salivary gland hypofunction in the
studies not using the above mentioned reference methods
are presented in Table 4.
Diagnostic accuracy
In all studies, the results of the test method were com-
pared to those of a reference method [4,31-47]. These
studies were interpreted according to the protocol based
on the QUADAS tool [30].
Based on this, it can be reported that the patient selec-
tion criteria were not clearly described [38-40,47], and the
test method [4] or the reference method [4,33,39,41,44]
were not described in sufficient detail to allow the study
to be reproduced. None of the included studies reported
uninterpretable/intermediate results or data on observer
or instrument variation. Authors’ judgements regarding
seven of the quality items in the QUADAS tool (Table 2,
questions no 1,4,6,9,10,11,12 and 13) are presented in
Figure 2.
Table 3 Data of study populations and control groups in the studies included in the review
First author,
year of publication
Study population Control group




Age and gender not stated
Almståhl 2003 [32] 39 subjects: 12 control subjects
−9 subjects with history of head and neck radiation (10 females/2 males) with normal
salivary secretion rates
Mean age 54 yrs(2 females/8 males
c)
Mean age 55 yrs
−10 subjects with pSS
(10 females)
Mean age 57 yrs
−10 subjects treated with neuroleptic injections
(4 females/6 males)
Mean age 44 yrs




Mean age 54 yrs
El-Miedany 1999 [33] 25 subjects: 15 healthy age-matched controls
−15 with pSS Mean age 50 yrs
−10 with sSS 10 younger controls
(20 females/5 males) Mean age 26.2 yrs
Mean age 48 yrs Gender not stated
Håkansson 1994 [34] 17 subjects with pSS (15 females/2 males) 30 subjects with symptoms of dry
mouth and/or eyes
Mean age 63 yrs (21 females/9 males)
Mean age 69 yrs
12 subjects without symptoms of dry
mouth and/or eyes
(6 females/6 males)
Mean age 68 yrs
Hay 1998 [35] 341 subjects:
−189 females
Age (median) 49 yrs
−152 males
Age (median) 46 yrs
First author, year
of publication
Study population Control group
Kalk 2001 [36] 100 consecutive subjects: 36 healthy subjects
−33 with pSS (20 females/16 males)
(30 females/3 males) Mean age 39 yrs
Mean age 51 yrs
−25 with sSS
(21 females/4 males)
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Table 3 Data of study populations and control groups in the studies included in the review (Continued)
Mean age 54 yrs
−42 tested negative for SS
(40 females/2 males)
Mean age 55 yrs





Mean age 62 yrs
−13 non-SS
(13 females)
Mean age 55 yrs
Kanehira 2009 [38] 9 subjects with complaints of decreased
salivary flow rate
31 healthy subjects
Age and gender reported for
all included subjects
(22 females/19 males)
Mean age 48.8 yrs
Kohn 1992 [39] 22 subjects: 33 healthy volunteers
−19 with pSS (20 females/13 males)
−1 with sSS Mean age 54.4 yrs
−2 with idiopathic xerostomia
(17 females/5 males)
Mean age 52.2 yrs
Lee 2002 [40] 20 subjects with dry mouth 20 age/gender matched healthy
control subjects
(unstimulated whole saliva flow rate <0.15 ml/min) (18 females/2 males)
(18 females/2 males) Mean age 42.6 yrs
Mean age 43.6 yrs
First author, year of publication Study population Control group
López-Jornet 2006 [41] 92 subjects: 70 healthy volunteers
−61 with pSS or sSS (35 females/35 males)
(50 females/11 males) Mean age 40.53 yrs
Mean age 57.08 yrs
−31 displaying symptoms of oral
dryness from different causes
(29 females/2 males)
Mean age 52.52 yrs
Navazesh 1992 [42] A total of 71 subjects were included. Unclear
Approx. half with salivary gland hypofunction,
defined as unstimulated whole salivary
flow rate ≤0.20 ml/min
Approx. half of the total number of
included subjects. Individuals with
normal salivary flow rates.
(48 females/23 males)
Mean age 52 yrs
Pedersen 1999 [43] 16 subjects: 14 healthy volunteers
(14 females/2 males) meeting the 1993
European classification for pSS.
(13 females/1 male)
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Table 3 Data of study populations and control groups in the studies included in the review (Continued)
Mean age unclear Mean age 50 yrs
13 healthy volunteers
(12 females/1 male)
Mean age 24 yrs
Pennec 1993 [44] 72 consecutive subjects: 14 healthy subjects
- 40 subjects with pSS Mean age 64.7 yrs
−16 subjects with sSS Gender not stated
−16 subjects with connective tissue
disease but no evidence of sSS
(70 females/2males)
Mean age 59.4 yrs
Sánchez-Guerrero 2002 [45] 90 subjects: 152 healthy subjects
−30 subjects with pSS (106 females/46 males)
(29 females/1 male) Mean age 35.2 yrs
Mean age 50.6 yrs
−60 subjects with CTDs without SS
(50 females/10 males)
Mean age 37.4 yrs
First author, year of publication Study population Control group
Sreebny 1988 [4] 151 subjects with reported dry mouth 372 subjects without reported dry mouth
(109 females/42 males) (219 females/159 males)
Age range 18–55+ Age range 18–55+
Wolff 1998 [46] 50 subjects: 25 subjects with no perception of dry mouth
and no medication with resting salivary
flow rates > 1.0 ml/min
−25 subjects with complaints of ‘dry mouth’ due






−25 subjects with complaints of ‘dry
mouth’ due to medication, with resting
salivary flow rates > 0.1 ml/min
(18/females/7 males)
Mean age 49.2
Wolff 2002 [47] 27 subjects with complaints of dry mouth 32 healthy subjects
Age and gender not stated Age and gender not stated
a pSS = primary Sjögren’s syndrome.
b sSS = secondary Sjögren’s syndrome.
c Female/male ratio according to table in original study.
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sented their results as a percentage of correct diagnoses.
Secretion tests
One study [31] examined the application of three
different gel electrophoresis systems (SDS-PAGE,
anionic-PAGE, immobilized pH gradient (IPG)) in
the diagnosis of Sjögren’s syndrome. Tests of accur-
acy revealed that the immobilized pH gradingsystem had a specificity of 97%, sensitivity of 95%,
positive predictive value of 97% and negative pre-
dictive value of 95% in the diagnosis of Sjögren’s
syndrome.
In the study by Kalk et al. [37], reference values
of several salivary variables, i.e. sodium, chloride
and phosphate concentration in stimulated parotid
and submandibular/sublingual saliva, unstimulated
and stimulated submandibular/sublingual flow rates
Table 4 Data of index test methods and reference methods in the studies included in the review
First author, year of publication Test method Reference method Authors’ conclusion





of Sjögren’s syndrome [42]
Salivary electrophoresis is a potentially






Almståhl 2003 [32] Sialochemistry The Copenhagen criteria
for Sjögren’s syndrome [47]
The concentrations of electrolytes in
stimulated whole saliva, in individuals
with hyposalivation, seem to be more
related to the reason for the
hyposalivation than to the salivary
secretion rate.
El-Miedany 1999 [33] Salivary smears Criteria of Fox et al. for
Sjögren’s syndrome [48]
The saliva ferning test is a useful
diagnostic aid in autoimmune
xerostomia, approx equivalent to
Shrimer’s test in xeropthalmia
Håkansson 1994 [34] 99mTc-scintigraphy ▪Copenhagen criteria
for pSS [47]
Salivary gland scintigraphy is a sensitive
and valid method to measure salivary




Hay 1998 [35] Questionnaire ▪Sialometry [42-44] Only weak associations were found
between self-reported symptoms of
dry eyes and dry mouth and objective
measures said to define Sjögren’s





Kalk 2001 [36] ▪Sialometry Revised European classification
criteria for SS [43-45]
Glandular sialometry and sialochemistry
are not useful tools for differentiating SS
from other salivary gland disease.
▪Sialochemistry Parotid sialography was used to
fulfill the criteria on the
oral component.
Kalk 2002 [37] ▪Sialometry Revised European classification
criteria for SS [43-45]
Gland-specific sialometry and sialochemistry
may eventually replace other, more
invasive, diagnostic techniques for
diagnosing SS.
▪Sialochemistry Parotid sialography was used to
fulfill the criteria on the
oral component.
Kanehira 2009 [38] Filter paper comprising
3 spots containing
30 μg starch and 49.6 μg
potassium iodide per spot.
Sialometry (unstimulated whole
saliva < 0.1 ml/min)a
This screening technique might be
effective for estimation of salivary flow.
Kohn 1992 [39] 99mTc-scintigraphy Sialometry (Unstimulated parotid
and SM/SL < 0.1 ml/min Stimulated
parotid and SM/SL < 0.6 ml/min)*
Salivary gland scintigraphy is a useful
method in assessing salivary
gland flow rates
Lee 2002 [40] ▪Oral mucosal wetness Sialometry (unstimulated whole
saliva <0.15 ml/min) a
Measurements of oral mucosal wetness
could be thought of as one of the
diagnostic methods for assessing
dry mouth.
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López-Jornet 2006 [41] Oral Schirmer’s test Revised European classification
criteria for SS [46]
Oral Shrimer’s test can be used as a simple,
objective test to diagnose salivary gland
hypofunction.
Navazesh 1992 [42] ▪Lip dryness Sialometry (unstimulated whole
saliva ≤0.20 ml/min) a
Four clinical measures that together
predict the presence of or absence
of salivary gland hypofunction were
identified: dryness of lips, dryness of
buccal mucosa, absence of saliva produced








Pedersen 1999 [43] ▪Sialometry European classification
for pSS [42]
Rating of oral dryness by visual
analogue scales or categorised
questionnaires are valuable for the
evaluation of oral involvement in pSS.





Pennec 1993 [44] ▪Sialometry European classification
for pSS [42]
The most efficient combination of tests for
the oral component of SS appears to be
salivary gland scintigraphy plus saliva flow










Wafer test For the oral component parotid
secretion rate
according to Fox et al. [48]
The wafer test is valid and reliable for




Sreebny 1988 [4] Questionnaire Sialometry (unstimulated whole
saliva≤ 0.1 ml/min) a
Dry mouth and several other symptoms are
common in an outpatient population and
they are a valid indicator of salivary gland
hypofunction




saliva≤ 0.1 ml/min) a Salivary pH
Measurement of palatal mucosal
wetness might be useful in assessing
medication compliance and may serve
as a guide to medication administration.
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Table 4 Data of index test methods and reference methods in the studies included in the review (Continued)
Wolff 2002 [47] 3-g-all-sucrose candy Sialometry (unstimulated SM/SL
< 0.1 ml/min + either stimulated
parotid <0.25 ml/min or stimulated
SM/SL < 0.15 ml/min) a
The candy weight-loss test is a
measure of salivary hypofunction,
which correlates with saliva output
and reports of subjective dry mouth
a Cut-off value defining salivary gland hypofunction.
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to diagnose Sjögren’s syndrome. The most accurate test,
with a sensitivity of 85% and specificity of 96%, combined
stimulated submandibular/sublingual flow rate and par-
otid sodium and chloride concentration.
Oral Schirmer’s test was used as test method in one
study [41] for detecting salivary gland hypofunction.
Cut-off values for the unstimulated test (≤ 30 mm/
5 min, ≤ 40 mm/5 min, ≤ 50 mm/5 min, ≤ 60 mm/5 min),
and for the stimulated test (≤ 50 mm/5 min, ≤ 60 mm/
5 min, ≤ 70 mm/5 min, ≤ 80 mm/5 min) were examined
and sensitivity, specificity, positive predictive values and
negative predictive values were calculated. A cut-off value
of ≤30 mm/5 min for the unstimulated sialometric test
using Oral Shirmer’s test provided a sensitivity of 67.9%
and a specificity of 62.8%. A cut-off value of≤ 80 mm/
5 min for the stimulated test showed a sensitivity of
87.6%, specificity of 67.5%, positive predictive value of
55.7% and a negative predictive value of 7.8%.
Functional tests
A wafer test was used as a test method in one study [45]
to predict early salivary gland dysfunction and xerosto-
mia. Different cut-off values (3–7 min) were examined
and the best balance between sensitivity and specificity
was seen with a cut-off value of 4 min (wafer 4). This
cut-off value exhibited a sensitivity of 92.9%, specificity
of 71.7%, positive predictive value of 31.7%, negative pre-
dictive value of 98.6% and accuracy of 74.3%. With in-
creasing time, the specificity for reduced salivary flow
increased. Wafer 4 was compared with the European
questionnaire [48] in order to validate the test as a
screening instrument for low salivary flow and xerosto-
mia. For low salivary flow, the European questionnaire
[48] and the wafer 4 showed identical sensitivity. How-
ever, wafer 4 showed higher specificity, positive predict-
ive value, negative predictive value, and accuracy. For
xerostomia, wafer 4 showed higher sensitivity and nega-
tive predictive value when compared to the European
questionnaire [48].
An indirect method (candy weight loss) was used as a
test method in one study [47] to determine salivary out-
put level. Significant associations were found when com-
paring candy weight loss with stimulated parotid and
submandibular and sublingual saliva. When using a cut-
off value of 0.23 g candy loss, the sensitivity was 92%,
specificity 85% and the positive predictive value 82%.Questionnaires
Sreebny and Valdini [4] determined the validity of using
symptoms related to dry mouth by using a question-
naire, to screen patients for salivary gland hypofunction.
The study population was classified into three groups
according to their ability to produce unstimulated whole
saliva. Flow rates of ≤ 0.1 ml/min were characterised as
“abnormal”, between 0.11 and 0.2 ml/min as “low nor-
mal”, and > 0.2 ml/min as “normal”. Determinations of
sensitivity, specificity and negative and positive predict-
ive values were made for xerostomia alone and for xer-
ostomia in combination with three symptoms that were
closely associated with it. A positive answer to the ques-
tion “Does your mouth usually feel dry” showed a sensi-
tivity of 93%, specificity of 68%, positive predictive value
of 54% and negative predictive value of 98%. When an
additional three symptoms were taken into account (dif-
ficulty with speech, trying to keep mouth moist and get-
ting out of bed to drink), the specificity increased to 91%
and the positive predictive value increased to 75%.
Secretion/glandular morphology
A combination of tests for the classification of the oral
component of Sjögren’s syndrome was examined in the
study by Pennec et al. [44]. The tests examined were sal-
ivary flow rate (unstimulated whole saliva), salivary lyso-
zyme, salivary lactoferrin, sialography, salivary gland
scintigraphy and labial salivary gland biopsy. The
authors concluded that the most efficient combination
of test for the oral component of Sjögren’s syndrome
was salivary gland biopsy (sensitivity 95%, specificity
75%, positive predictive value 90%, negative predictive
value 14%) plus salivary flow rate (sensitivity 68%, speci-
ficity 81%, positive predictive value 90%, negative pre-
dictive value 50%) or salivary lactoferrin (sensitivity 58%,
specificity 75%, positive predictive value 82%, negative
predictive value 53%).
Discussion
The aim of systematic reviews is to identify and evaluate
all available research evidence relating to a particular ob-
jective. An essential part of any systematic review is the
quality assessment of individual studies. Aspects such as
study design, methods of sample recruitment, the execu-
tion of the tests and the completeness of the study re-
port relate to the overall quality. The results of a
systematic review will be biased if the results of
Table 5 Salivary secretions used as reference method in
the included studies
First author, year of publication Secretion
Al-Hashimi 1998 [31] Stimulated parotid saliva
(2%citric acid)
Almståhl 2003 [32] Unstimulated whole saliva
El-Miedany 1999 [33] Unstimulated whole saliva
Håkansson 1994 [34] Unstimulated whole saliva
Hay 1998 [35] Unstimulated whole saliva
Kalk 2001 [36] Unstimulated and stimulated
(2% citric acid) parotid and
SM/SL saliva
Kalk 2002 [37] Unstimulated and stimulated
(2% citric acid)parotid and
SM/SL saliva
Kanehira 2009 [38] Unstimulated whole saliva
Kohn 1992 [39] Unstimulated and stimulated
(2% citric acid) parotid and
SM/SL saliva
Lee 2002 [40] Unstimulated whole saliva
López-Jornet 2006 [41] Unstimulated and stimulated
(4% citric acid) whole saliva
Navazesh 1992 [42] Unstimulated and stimulated
(inert gum base) whole saliva
and stimulated (candy-stimulated
and acid-stimulated 0.15 mol/L
citric acid) parotid saliva.
Pedersen 1999 [43] Unstimulated whole saliva
Pennec 1993 [44] Unstimulated whole saliva
Sánchez-Guerrero 2002 [45] Unstimulated whole saliva
Sreebny 1988 [4] Unstimulated and stimulated
(paraffin) whole saliva
Wolff 1998 [46] Unstimulated whole saliva
Wolff 2002 [47] Unstimulated and stimulated (2%
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http://www.biomedcentral.com/1472-6831/12/29individual studies are synthesised without any consider-
ation of quality in terms of potential for bias, lack of ap-
plicability and the quality of reporting.
QUADAS [30] was the first systematically developed,
evidence based quality assessment tool to be used in sys-
tematic reviews of diagnostic accuracy studies. The
QUADAS tool [30] contains a detailed explanation of
the intention of each item, situations when the item does
not apply and how to score items. This allows for minor
adaptations in specific areas. The QUADAS tool [30]
does not incorporate quality scores to assess the level of
evidence. Since the importance of individual items and
their potential biases may vary according to the context
in which they are applied, incorporation of quality scores
into the results of a review may generate different mag-
nitudes of bias and lead to different conclusions regard-
ing the effect of study quality on estimates of diagnostic
accuracy. Instead, it has been proposed that a systematic
review should involve a component approach, where the
association of individual quality items with test accuracy
are investigated individually [55].
The QUADAS tool [30] was used in the present sys-
tematic review since it is a standardised approach to
quality assessment and since the criteria needed to as-
sess the quality of diagnostic test evaluations differ from
those needed to assess evaluations of therapeutic inter-
ventions [56].
In the present review, modifications were done to
adapt the QUADAS tool [30] to better correspond to the
objectives of the study. Two questions (numbers 6 and
7) were excluded from the 14 questions of the final
QUADAS tool [30] and two were added from the ori-
ginal list of 28. In addition, question number 3 was
modified into two sub-questions.
When interpreting the studies with the aid of the




tems presented as percentages across all included studies.
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criteria clearly and in describing the test method or the
reference method in such detail that it could be repro-
duced. A sufficient description of the tests is important
since variations in measures of diagnostic accuracy can
be traced back to differences in the execution of the
tests. A clear description is also needed in order to im-
plement the test in another setting. None of the included
studies reported uninterpretable/intermediate results or
data on observer or instrument variation. A diagnostic
test can produce uninterpretable/intermediate results
with varying frequency. If these results are removed from
the analysis, it may lead to biased assessments of the test
characteristics. Furthermore, it can be questioned if some
of the studies presented appropriate results.
When scoring QUADAS items [30] as unclear it is dif-
ficult to be certain if this indicates poor methods with
the attendant consequences for bias and/or variation, or
simply poor reporting of a methodologically sound
study. The STARD initiative [57] has proposed standards
for the reporting of diagnostic accuracy studies. If these
standards are widely adopted, reviewers might be able to
assess methodological quality rather than the quality of
reporting. The aim of test accuracy studies is to assess
how well a test can distinguish between subjects with
and without the disease/condition of interest. There are
two basic types of test accuracy study: (1) The single-
gate design which includes participants in whom the dis-
ease status is unknown, and compares the results of the
index test with those of a reference standard used to
confirm diagnosis. This design is broadly representative
of the setting in which the test would be used in prac-
tice. (2) The two-gate design compares the results of the
index test in patients with an established diagnosis of
the target condition with its results in healthy controls
or controls with another diagnosis. This design has in-
herent problems that may lead to bias. The inclusion of
healthy controls is likely to lead to over estimations of
specificity and the selective inclusion of cases with more
advanced disease is likely to lead to over estimations of
sensitivity [58]. The two-gate studies can however be
useful in the earlier phases of test development.
Addressing the question formulated to specify the
problem, it can be concluded that whilst a variety of
tests to diagnose oral dryness have been examined,
only a few have been validated in terms of diagnostic
accuracy. Eight of the included studies presented their
results as percentage of correct diagnoses. Four of these
studies used European Community Study Group on clas-
sification criteria for Sjögren’s syndrome [48-52] as refer-
ence method. The European classification criteria for
Sjögren’s syndrome were developed and validated between
1989 and 1996 and have received broad acceptance by the
scientific community. Since the reference standard is animportant determinant of the diagnostic accuracy of a test,
it raises the question of why all of studies aimed at the
evaluation of tests for the diagnosis of Sjögren’s syndrome
did not use the same reference method.
Although these criteria have received a broad accept-
ance, some criticism has been raised concerning the in-
clusion of subjective test (symptoms), physiologic
measures that lack specificity and alternate objective
tests that are not diagnostically equivalent.
Recently, the American College of Rheumatology [59]
proposed new classification criteria for Sjögren’s syn-
drome. These criteria are based on expert opinion eli-
cited using the nominal group technique and analyses of
data from the Sjögren’s International Collaborative Clin-
ical Alliance [60]. The proposed criteria are: 1) positive
serum anti-SSA and/or anti-SSB or (positive rheumatoid
factor and antinuclear antibody titer ≥1:320), 2) ocular
staining score ≥3, or 3) presence of focal lymphocytic
sialadenitis with a focus score ≥1 focus/4 mm2 in saliv-
ary gland biopsy samples. Case definition requires at
least 2 of the 3 above mentioned objective features.
Thus, only objective tests and not subjective tests (symp-
toms) are included since symptoms of dry mouth and/or
eyes can lead to misclassification of asymptomatic
patients. For the salivary and ocular phenotypic features
of Sjögren’s syndrome the results did not identify any
suitable alternate tests besides labial salivary gland bi-
opsy. While unstimulated salivary flow rate <0.1 ml/min
had good sensitivity, it had low specificity compared to
the labial salivary gland biopsy to measure focal lympho-
cytic sialadenitis with a focus score ≥1 [59]. Seven of the
studies interpreted in this review evaluated different
tests for determining decreased salivary flow and used
sialometry as a reference method. These studies revealed
heterogeneity with respect to source of secretion
whether unstimulated or stimulated. Cut-off values de-
fining salivary gland hypofunction also varied. As stated
earlier, without proper individual baseline information, it
is almost impossible to ascertain if the level of a patient’s
salivary flow rate is below the ‘normal’. When using sia-
lometry for diagnosing salivary dysfunction it can be
argued if the method is used as a diagnostic tool or ra-
ther as a verification of an already established condition.
Sreebny [61] proposed that the low cut-off values should
be viewed as values which “flag” or “raise suspicion”
about the presence of a disease. They do not indicate
that the person who demonstrates such values definitely
has a disease.
The fact that there is no global consensus regarding
the terminology of oral dryness, although many authors
distinguish between xerostomia, denoting the subjective
feeling, and hyposalivation, denoting a decreased salivary
flow rate, creates a problem for research, diagnosis, and
therapy. As for research, this problem is illustrated when
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National Library of Medicine’s controlled vocabulary
thesaurus used for indexing articles for PubMed. The
MeSH database defines xerostomia as decreased salivary
flow, which is incorrect since a sensation of oral dryness
can occur in subjects with a normal salivary flow. Neder-
fors [12] proposed to divide the term “salivary gland
hypofunction” into 3 different entities: xerostomia, de-
noting the subjective feeling; hyposalivation, denoting
the decreased salivary flow rate; and altered saliva com-
position. This classification accepts that xerostomia may
exist without signs of hyposalivation, that hyposalivation
may be a symptomless condition and that an altered sal-
iva composition may exist even if the saliva secretion
rate is unaffected and without subjective symptoms.
These three entities are inter-related and can influence
each other in different ways.
Over the last decade, advances have been made
regarding proteomic and genomic approaches to identify
potential biomarkers that may be used in the detection
of different diseases, e.g. Sjögren’s syndrome [62]. Saliva
is a biofluid that is readily accessible via noninvasive
methods, and therefore a perfect medium to be explored
for purposes to monitor health status, disease onset and
progression, and treatment outcome. Salivary diagnostic
technologies identifying specific biomarkers associated
with disease may in the future be used to verify general
diseases behind salivary gland hypofunction [63]. It
should also be mentioned that in the absence of an effi-
cient treatment, a diagnostic method has little value.
The basic causes of oral dryness are difficult to treat and
many methods have been tested to stimulate saliva se-
cretion and ease the patient’s discomfort, e.g., saliva-
stimulating tablets and artificial saliva. Several studies
have evaluated the efficacy of such preparations but
there is no documented evidence of their effect on oral
health [64-66].
Currently, diagnostic methods are addressing quantity
and content of saliva in bulk and few qualitative tests of
saliva, in bulk or of saliva as an adsorbed thin film, are
at this date available for describing the protective func-
tions of saliva.
Since changes in the protective functions of saliva may
occur, there is a need for effective diagnostic criteria and
functional tests in order to discern which individuals
with oral dryness will require oral treatment, such as al-
leviation of discomfort and/or prevention of diseases.
An important component in determining the useful-
ness of a test is the evaluation of the diagnostic ac-
curacy, but the clinical value lies in improving a
patient’s condition or health. The clinical value, i.e.
how the results of a test affects the clinical decision-
making and the effect on the patient’s wellbeing are
important factors when evaluating diagnostic tests ormethods. A method with high diagnostic accuracy
may not always be efficient and useful for the patient.
Studies that investigate the value of diagnostic inter-
ventions are scarce and seldom available for new test
methods. In addition, appropriate reference standards
for many disorders are lacking.
Conclusions
The aim of this systematic review was to evaluate the
quality of evidence for diagnostic methods used to iden-
tify oral dryness and their clinical application.
After assessing the quality of the retrieved studies,
it may be concluded that the evidence for the efficacy
of clinical methods to assess oral dryness is sparse.
When evaluating the retrieved studies by using the
QUADAS tool [30], many of the studies exhibited
shortcomings. Standards for the reporting of diagnos-
tic accuracy studies have been suggested, such as the
STARD initiative [30]. If these standards are widely
adopted, the quality of reporting will be improved
and the methodological quality of diagnostic accuracy
studies will be easier to assess. This will, as a conse-
quence, benefit patients.
A global consensus regarding the terminology of oral
dryness is needed in order to facilitate diagnosis and
treatment and continued research.
Changes in the protective functions of saliva may
occur, which might affect oral health.
There is a need for effective diagnostic criteria and
functional tests in order to detect those individuals with
oral dryness who may require treatment, such as allevi-
ation of discomfort and/or prevention of diseases.
Additional file
Additional file 1: Table S1. The protocol used in the assessment
against the stated inclusion criteria.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
CDL and CC conceived the study. CDL, CW, MS and CC designed the study
and CDL was responsible for the literature search. PTL was responsible for
the search strategy. CDL, CW, MS and CC appraised the identified
publications. CDL drafted the manuscript. All authors read and approved the
final manuscript.
Acknowledgements
This study was supported by the Faculty of Odontology, Malmö University
and the Swedish Dental Society.
Author details
1Department of Materials Science and Technology, Faculty of Odontology,
Malmö University, Malmö, Sweden. 2Department of Oral Biology, Faculty of
Odontology, Malmö University, Malmö, Sweden. 3Department of
Orthodontics, Faculty of Odontology, Malmö University, Malmö, Sweden.
4Library and IT Services, Digital Information Services, Malmö University,
Löfgren et al. BMC Oral Health 2012, 12:29 Page 15 of 16
http://www.biomedcentral.com/1472-6831/12/29Malmö, Sweden. 5Department of Materials Science and Technology, Faculty
of Odontology, Malmö University, Malmö, Sweden.
Received: 19 September 2011 Accepted: 16 July 2012
Published: 8 August 2012
References
1. Levine MJ: Salivary molecules. A structure/function synopsis. In Saliva as a
Diagnostic Fluid. Edited by Malamud D, Tabak LA. New York: Annals of the
New York Academy of Sciences; 1993:11–16.
2. Osterberg T, Landahl S, Hedegard B: Salivary flow, saliva, pH and buffering
capacity in 70-year-old men and women. Correlation to dental health,
dryness in the mouth, disease and drug treatment. J Oral Rehabil 1984,
11:157–170.
3. Ben-Aryeh H, Miron D, Berdicevsky I, Szargel R, Gutman D: Xerostomia in
the elderly: prevalence, diagnosis, complications and treatment.
Gerodontology 1985, 4:77–82.
4. Sreebny LM, Valdini A: Xerostomia: Part I: Relationship to other oral
symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral
Pathol 1988, 66:451–458.
5. Thorselius I, Emilson CG, Osterberg T: Salivary conditions and drug
consumption in older age groups of elderly Swedish individuals.
Gerodontics 1988, 4:66–70.
6. Gilbert GH, Heft MW, Duncan RP: Mouth dryness as reported by older
Floridians. Community Dent Oral Epidemiol 1993, 21:390–397.
7. Locker D: Subjective reports of oral dryness in an older adult population.
Community Dent Oral Epidemiol 1993, 21:165–168.
8. Narhi TO: Prevalence of subjective feelings of dry mouth in the elderly.
J Dent Res 1994, 73:20–25.
9. Loesche WJ, Bromberg J, Terpenning MS, Bretz WA, Dominguez BL,
Grossman NS, et al: Xerostomia, xerogenic medications and food
avoidances in selected geriatric groups. J Am Geriatr Soc 1995,
43:401–407.
10. Billings RJ, Proskin HM, Moss ME: Xerostomia and associated factors in a
community-dwelling adult population. Community Dent Oral Epidemiol
1996, 24(Billings RJ, Proskin HM, Moss ME):312–316.
11. Hochberg MC, Tielsch J, Munoz B, Bandeen-Roche K, West SK, Schein OD:
Prevalence of symptoms of dry mouth and their relationship to saliva
production in community dwelling elderly: the SEE project, Salisbury Eye
Evaluation. J Rheumatol 1998, 25:486–491.
12. Nederfors T: Xerostomia and hyposalivation. Adv Dent Res 2000,
14:48–56.
13. Field EA, Longman LP, Bucknall R, Kaye SB, Higham SM, Edgar WM: The
establishment of a xerostomia clinic: a prospective study. Br J Oral
Maxillofac Surg 1997, 35:96–103.
14. Fox PC: Management of dry mouth. Dent Clin North Am 1996, 41:863–875.
15. Fox PC, van der Ven PF, Sonies BC, Weiffenbach JM, Baum BJ: Xerostomia:
evaluation of a symptom with increasing significance. J Am Dent Assoc
1985, 110:519–525.
16. Jensen JL, Barkvoll P: Clinical implications of the dry mouth. Ann NY Acad
Sci 1998, 842:156–162.
17. Locker D: Xerostomia in older adults: a longitudinal study. Gerodontology
1995, 12:18–25.
18. Nederfors T, Isaksson R, Mörnstad H, Dahlöf C: Prevalence of perceived
symptoms of dry mouth in an adult Swedish population- relation to age,
sex and pharmacotherapy. Community Dent Oral Epidemiol 1997,
25:211–216.
19. Ship JA, Baum BJ: Is reduced salivary flow normal in old people? Lancet
1990, 336:1507.
20. Osterberg T, Birkhed D, Johansson C, Svanborg A: Longitudinal study of
stimulated whole saliva in an elderly population. Scand J Dent Res 1992,
100:340–345.
21. Ericsson Y, Hardwick L: Individual diagnosis, prognosis and counseling for
caries prevention. Caries Res 1978, 12:94–102.
22. Fox PC, Busch KA, Baum BJ: Subjective reports of xerostomia and
objective measures of salivary gland performance. J Am Dent Assoc 1987,
115:581–584.
23. Sreebny LM, Valdini A, Yu A: Xerostomia. Part II: Relationship to nonoral
symptoms, drugs, and diseases. Oral Surg Oral Med Oral Pathol 1989,
68:419–427.24. Löfgren CD, Isberg PE, Christersson C: Screening for oral dryness in
relation to salivary flow rate addresses the need for functional tests of
saliva. Oral Health Prev Dent 2010, 8:243–252.
25. Ship JA, Fox PC, Baum BJ: How much saliva is enough? J Am Dent Assoc
1991, 122:63–69.
26. Ghezzi EM, Lange LA, Ship JA: Determination of Variation of Stimulated
Salivary Flow Rates. J Dent Res 2000, 11:1874–1878.
27. Dawes C: Circadian rhythms in human salivary flow rate and
composition. J Physiol 1972, 220:529–545.
28. Burlage FR, Pijpe J, Coppes RP, Hemels MEW, Meertens H, Canrinus A,
Vissink A: Variability of flow rate when collecting stimulated parotid
saliva. Eur J Oral Sci 2005, 113:386–390.
29. Goodman C: Literature Searching and Evidence Interpretation for Assessing
Health Care Practices. Stockholm: Swedish Council on Technology
Assessment in Health Care; 1993.
30. Whiting P, Rutjes AWS, Reitsma JB, Bossuyt PMM, Kleijnen J: The
development of QUADAS: a tool for the quality assessment of studies of
diagnostic accuracy included in systematic reviews. BMC Med Res
Methodol 2003, 3:25.
31. Al-Hashimi I, Haghighat N, Fox PC: Salivary electrophoresis in the
diagnosis of Sjogren’s syndrome. Oral Surg Oral Med Oral Pathol Oral
Radiol Endod 1998, 85:542–547.
32. Almståhl A, Wickström M: Electrolytes in stimulated whole saliva in
individuals with hyposalivation of different origins. Arch Oral Biol 2003,
48:337–344.
33. El-Miedany Y, El-Hady SM, El-Baddin MA: Validity of the Saliva Ferning Test
for the Diagnosis of Dry Mouth in Sjögren’s Syndrome. Rev Rhum Engl Ed
1999, 66:73–78.
34. Håkansson U, Jacobsson L, Lilja B, Manthorpe R, Henriksson V: Salivary
Gland Scintigraphy in Subjects with and without Symptoms of Dry
Mouth and/or Eyes, and in Patients with primary Sjögren’s syndrome.
Scand J Rheumatol 1994, 23:326–333.
35. Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ: Weak
association between subjective symptoms of and objective testing for
dry eyes and dry mouth: results from a population based study. Ann
Rheum Dis 1998, 57:20–24.
36. Kalk WWI, Vissink A, Spijkervet FKL, Bootsma H, Kallenberg CGM, Amerongen
AVN: Sialometry and sialochemistry: diagnostic tools for Sjögren’s
syndrome. Ann Rheum Dis 2001, 60:1110–1116.
37. Kalk WWI, Vissink A, Stegenga B, Bootsma H, Amerongen AVN, Kallenberg
CGM: Sialometry and sialochemistry: a non-invasive approach for
diagnosing Sjögren’s syndrome. Ann Rheum Dis 2002, 61:137–144.
38. Kanehira T, Yamaguchi T, Takehara J, Kashiwazaki H, Abe T, Morita M, Asano
K, Fujii Y, Sakamoto W: A pilot study of a simple screening technique for
estimation of salivary flow. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 2009, 108:389–393.
39. Kohn WG, Ship JA, Atkinson JC, Patton LL, Fox PC: Salivary gland
99mTc-scintigraphy: a grading scale and correlation with major salivary
gland flow rates. J oral Pathol Med 1992, 21:70–74.
40. Lee SK, Lee SW, Chung SC, Kim YK, Kho HS: Analysis of residual saliva and
minor salivary gland secretions in patients with dry mouth. Arch Oral Biol
2002, 47:637–641.
41. López-Jornet P, Camacho-Alonso F, Bermejo-Fenoll A: A simple test for
salivary gland hypofunction using Oral Schirmer’s test. J Oral Pathol Med
2006, 35:244–248.
42. Navazesh M, Christensen C, Brightman V: Clinical Criteria for the Diagnosis
of Salivary Gland Hypofunction. J Dent Res 1992, 7:1363–1369.
43. Pedersen AM, Reibel J, Nauntofte B: Primary Sjögren’s syndrome (pSS):
subjective symptoms and salivary findings. J Oral Pathol Med 1999,
28:303–311.
44. Pennec YL, Letoux G, Leroy JP, Youinou P: Reappraisal of tests for
xerostomia. Clin Exp Rheumatol 1993, 11:523–528.
45. Sánchez-Guerrero J, Aguirre-Garcia E, Pérez-Dosal MR, Kraus A: The wafer
test: a semi-quantitative test to screen for xerostomia. Rheumatology
2002, 41:381–389.
46. Wolff M, Kleinberg I: Oral mucosal wetness in hypo- and normosalivators.
Arch Oral Biol 1998, 43:455–462.
47. Wolff A, Herscovivi D, Rosenberg M: A simple technique for determination
of salivary gland hypofunction. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 2002, 94:175–178.
Löfgren et al. BMC Oral Health 2012, 12:29 Page 16 of 16
http://www.biomedcentral.com/1472-6831/12/2948. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W,
Bernstein RM, et al: Preliminary criteria for the classification of Sjögren’s
syndrome. Results of a prospective concerted action supported by the
European Community. Arthritis Rheum 1993, 36:340–347.
49. Vitali C, Moutsopoulos HM, Bombardieri S: The European Study Group on
diagnostic criteria for Sjögren’s syndrome. Sensitivity and specificity of
tests for ocular and oral involvement of Sjögren’s syndrome. Ann Rheum
Dis 1994, 53:637–647.
50. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli L, Hatron PY, et al:
Assessment of the European classification criteria for Sjögren’s syndrome
in a series of clinically defined cases; results of a prospective multicentre
study. The European Study Group on Diagnostic Criteria for Sjögren’s
syndrome. Ann Rheum Dis 1996, 55:116–121.
51. Vitali C, Bombardieri S, Moutsopoulos HM, the European Study Group on
Diagnostic Criteria for Sjögren’s syndrome: The European classification
criteria for Sjögren’s syndrome (SS). Proposal for a modification of the
rules for classification suggested by the analysis of the receiver
operating characteristic (ROC) curve of the criteria performance
[abstract]. J Rheumatol 1997, 24:38.
52. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons
SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH,
the European Study Group on Diagnostic Criteria for Sjögren’s syndrome:
Classification criteria for Sjögren’s syndrome: a revised version of the
European criteria proposed by the American-European Consensus
Group. Ann Rheum Dis 2002, 61:554–558.
53. Manthorpe R, Oxholm P, Prause J, Schiødt M: The Copenhagen criteria for
Sjögren’s syndrome. Scand J Rheumatol 1986, 61:19–21.
54. Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV: Sjögren’s syndrome.
Proposed Criteria for Classification. Arthritis Rheum 1986, 29:577–585.
55. Whiting P, Harbord R, Kleijnen J: No role for quality scores in systematic
reviews of diagnostic accuracy studies. BMC Med Res Methodol 2005, 5:19.
56. Deeks JJ: Systematic reviews of evaluations of diagnostic and screening
tests. In Systematic Reviews in Health Care BMJ 2001, 323:157–162.
57. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwing LM,
Lijmer JG, Moher D, Rennie D, de Vet HC: Towards complete and accurate
reporting of studies of diagnostic accuracy. Radiol 2003, 226:24–28.
58. Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JH,
Bossuyt PM: Empirical evidence of design-related bias in studies of
diagnostic tests. JAMA 1999, 282:1061–1066.
59. Shiboski SC, Shiboski CH, Criswell A, Baer AN, Challacombe S, Lanfranchi H,
et al: American College of Rheumatology Classification Criteria for
Sjögren’s Syndrome: a Data-Driven, Expert Consensus Approach in the
Sjögren’s International Collaborative Clinical Alliance Cohort. Arthritis Care
Res 2012, 64:475–487.
60. Daniels TE, Criswell LA, Shiboski C, Shiboski S, Lanfranchi H, Dong Y, the
Sjögren’s International Collaborative Clinical Alliance Research Groups, et al:
An early view of the international Sjögren’s syndrome registry. Arthritis
Rheum 2009, 61:711–714.
61. Sreebny LM: Saliva in health and disease: an appraisal and update. Int
Dent J 2000, 50:140–161.
62. Hu S, Wang J, Meijer J, Ieong S, Xie Y, Yu T, et al: Salivary Proteomic and
Genomic Biomarkers for Primary Sjögren’s Syndrome. Arthritis Rheum
2007, 56:3588–3600.
63. Wong DT: Salivary diagnostics powered by nanotechnologies,
proteomics and genomics. J Am Dent Assoc 2006, 137:313–321.
64. Johnson G, Barenthin I, Westphal P: Mouthdryness among patients in
longterm hospitals. Gerodontology 1984, 3:197–203.
65. van der Reijden WA, van der Kwaak H, Vissink A, Veerman ECI, Amerongen
AVN: Treatment of xerostomia with polymer-based saliva substitutes in
patients with Sjögren’s syndrome. Arthritis and Rheumatism 1996,
39:57–63.
66. Kaarela K, Mutrtu O: Xerostomia in Sjögren’s syndrome treated with
sali-synt. Scan J Rheumatol 1982, 11:39–40.
doi:10.1186/1472-6831-12-29
Cite this article as: Löfgren et al.: A systematic review of methods to
diagnose oral dryness and salivary gland function. BMC Oral Health 2012
12:29.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
